HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Innovative Medical Device Development Center Opens in NY

By HospiMedica International staff writers
Posted on 11 May 2016
Print article
Image: Vascular testing model produced on the Stratasys Objet500 Connex3 3D printer (Photo courtesy of the Jacobs Institute).
Image: Vascular testing model produced on the Stratasys Objet500 Connex3 3D printer (Photo courtesy of the Jacobs Institute).
Three-dimensional (3D) printer manufacturer Stratasys (Rehovot, Israel) and the Jacobs Institute (JI; Buffalo, NY, USA) have created a research and development (R&D) center aimed at using 3D printing to test and develop new medical devices.

The new Center of Excellence (COE) will leverage Stratasys’ 3D printing technology to develop and test new medical devices using printed prototypes and models. The COE will also serve as a referral center for hospitals and medical research organizations that are considering implementing 3D printing labs, and will enrich clinical education and training activities for a variety of audiences. It is also expected to aid hospitals and medical research groups in their own implementation of in-house 3D printing labs, an increasingly common phenomenon.

Stratasys supports the COE by providing advanced 3D printing solutions that feature a combination of vibrant colors and diverse material properties, including different levels of opacity and rigidity. Other partners in the COE will include Kaleida Health (Buffalo, NY, USA), the largest healthcare provider in Western New York, and the State University of New York at Buffalo (USA). Kaleida Health will participate via its vascular institute, while the University at Buffalo will share its Clinical and Translational Research Center (CTRC).

“By partnering with Stratasys, the Jacobs Institute is bringing the leader in 3D printing to Buffalo to work closely with the JI and its partners, Kaleida Health and the University at Buffalo, to accelerate the development of new medical technologies,” said Bill Maggio, CEO of the Jacobs Institute. “Working together, the respective institutions will leverage their strengths to make an impact far greater than they could make individually.”

“This announcement with the Jacobs Institute is an important milestone, marking the first time we are formally partnering with a medical organization to explore the exciting opportunities of 3D printing and healthcare,” said Scott Rader, general manager of medical solutions at Stratasys. “Stratasys brings decades of experience to the Jacobs Institute, a leader in 3D printed models, to push the boundaries of how these models can be used to train the next generation of physicians, and test new devices.”

Related Links:
Stratasys
Jacobs Institute
Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Illuminator
Trimline Basic

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more